Haworth Annette, Kearvell Rachel, Greer Peter B, Hooton Ben, Denham James W, Lamb David, Duchesne Gillian, Murray Judy, Joseph David
Department of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia.
Radiother Oncol. 2009 Mar;90(3):299-306. doi: 10.1016/j.radonc.2008.10.011. Epub 2008 Nov 18.
A multi-centre clinical trial for prostate cancer patients provided an opportunity to introduce conformal radiotherapy with dose escalation. To verify adequate treatment accuracy prior to patient recruitment, centres submitted details of a set-up accuracy study (SUAS). We report the results of the SUAS, the variation in clinical practice and the strategies used to help centres improve treatment accuracy.
The SUAS required each of the 24 participating centres to collect data on at least 10 pelvic patients imaged on a minimum of 20 occasions. Software was provided for data collection and analysis. Support to centres was provided through educational lectures, the trial quality assurance team and an information booklet.
Only two centres had recently carried out a SUAS prior to the trial opening. Systematic errors were generally smaller than those previously reported in the literature. The questionnaire identified many differences in patient set-up protocols. As a result of participating in this QA activity more than 65% of centres improved their treatment delivery accuracy.
Conducting a pre-trial SUAS has led to improvement in treatment delivery accuracy in many centres. Treatment techniques and set-up accuracy varied greatly, demonstrating a need to ensure an on-going awareness for such studies in future trials and with the introduction of dose escalation or new technologies.
一项针对前列腺癌患者的多中心临床试验为引入剂量递增的适形放疗提供了契机。为在患者招募前验证治疗的足够准确性,各中心提交了摆位准确性研究(SUAS)的详细资料。我们报告了SUAS的结果、临床实践中的差异以及用于帮助各中心提高治疗准确性的策略。
SUAS要求24个参与中心中的每个中心收集至少10例盆腔患者的数据,这些患者至少接受20次成像。提供了用于数据收集和分析的软件。通过教育讲座、试验质量保证团队和一本信息手册为各中心提供支持。
只有两个中心在试验开始前最近进行了SUAS。系统误差通常小于先前文献报道的误差。调查问卷发现患者摆位方案存在许多差异。由于参与了这项质量保证活动,超过65%的中心提高了其治疗实施的准确性。
开展试验前的SUAS已使许多中心的治疗实施准确性得到提高。治疗技术和摆位准确性差异很大,这表明在未来试验以及引入剂量递增或新技术时,需要确保持续关注此类研究。